Skip to content

A single-center randomized controlled trial for exploration of the efficacy and safety of adipose-derived mesenchymal stem cells covering the uterine cavity surface for the treatment of intrauterine adhesions

A single-center randomized controlled trial for exploration of the efficacy and safety of adipose-derived mesenchymal stem cells covering the uterine cavity surface for the treatment of intrauterine adhesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICC-15006046
Enrollment
Unknown
Registered
2015-03-06
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesions

Interventions

One:Hysteroscopy, artificial cycle
Two:Hysteroscopy, adipose-derived mesenchymal stem cells

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: Intrauterine adhesions is due to mainly operating history of the uterine cavity, such as abortion, myomectomy, uterine curettage and other damage caused by the occurrence of endometrial lining of the uterus.

Exclusion criteria

Exclusion criteria: There are other pathological conditions may cause abnormal vaginal bleeding, such as endometrial polyps, submucosal uterine fibroids, gynecological tumors; 1. generally poor, difficult to tolerate serious medical complications of hysteroscopic surgery; 2. reproductive system, urinary system, or with active systemic infection, surgery can be postponed until after the infection cleared; 3. coagulation disorders or are receiving therapeutic anticoagulation drugs; 4. The researchers believe there may be other medical or mental illness can not be with the completion of the investigator.

Design outcomes

Primary

MeasureTime frame
effectiveness;

Secondary

MeasureTime frame
safety;

Countries

China

Contacts

Public ContactZhu Lan
zhu_julie@vip.sina.com+86 13911714696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026